Satoshi Serada

Yahaba, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 104 publications

Glypican-1-targeted antibody-drug conjugate shows therapeutic efficacy in lung squamous cell carcinoma.

Glypican-1-targeted antibody-drug conjugate shows therapeutic efficacy in lung squamous cell carcinoma.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: November 21, 2025

Umbilical Artery Leucine-Rich α-2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants.

Umbilical Artery Leucine-Rich α-2 Glycoprotein as a Predictor of Bronchopulmonary Dysplasia in Preterm Infants.

Journal: Pediatric pulmonology

Published: July 15, 2025

Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.

Overexpression of Transferrin Receptor in Esophageal Squamous Cell Cancer Suggests Poor Prognosis and Potential Therapy.

Journal: Cancer science

Published: April 23, 2025

Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells.

Targeting yes-associated protein to overcome imatinib resistance in gastrointestinal stromal tumor drug-tolerant persister cells.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: April 03, 2025

Predictive score using umbilical vein leucine-rich α-2 glycoprotein as a useful biomarker for diagnosing histological chorioamnionitis in preterm infants.

Predictive score using umbilical vein leucine-rich α-2 glycoprotein as a useful biomarker for diagnosing histological chorioamnionitis in preterm infants.

Journal: The journal of obstetrics and gynaecology research

Published: February 10, 2025

Assessing efficacy of anti-glypican-1 antibody-drug conjugate as potential therapeutic approach for gastric cancer.

Assessing efficacy of anti-glypican-1 antibody-drug conjugate as potential therapeutic approach for gastric cancer.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: October 07, 2024

KDM4B Histone Demethylase Inhibition Attenuates Tumorigenicity of Malignant Melanoma Cells by Overriding the p53-Mediated Tumor Suppressor Pathway.

KDM4B Histone Demethylase Inhibition Attenuates Tumorigenicity of Malignant Melanoma Cells by Overriding the p53-Mediated Tumor Suppressor Pathway.

Journal: Journal of cellular biochemistry

Published: May 16, 2024

Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer.

Lipolysis-stimulated lipoprotein receptor promote lipid uptake and fatty acid oxidation in gastric cancer.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: March 05, 2024

Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma.

Glypican-1-targeted antibody-drug conjugate inhibits the growth of glypican-1-positive glioblastoma.

Journal: Neoplasia (New York, N.Y.)

Published: January 04, 2024

Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.

Novel germline STAT3 gain-of-function mutation causes autoimmune diseases and severe growth failure.

Journal: The journal of allergy and clinical immunology. Global

Published: November 02, 2023

Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.

Leucine-rich α2-glycoprotein as a useful biomarker for evaluating disease activity in rheumatoid arthritis.

Journal: Modern rheumatology

Published: October 12, 2023

Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.

Immuno-PET and Targeted α-Therapy Using Anti-Glypican-1 Antibody Labeled with 89Zr or 211At: A Theranostic Approach for Pancreatic Ductal Adenocarcinoma.

Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Published: July 13, 2023

Showing 1-12 of 104

Last Updated: 09/26/2026